SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, a commercial-stage company delivering first-of-its-kind technology into the growing global dialysis market, today announced that it raised $132 million in a Series D equity financing. The round was led by new investor Mubadala Investment Company, Abu Dhabi’s leading investment company, active in numerous sectors and more than 30 countries around the world. Existing investors Baxter Ventures, the venture capital arm of Baxter International, Fidelity Management and Research Company, Partner Fund Management LP, Perceptive Advisors, funds advised by T. Rowe Price Associates Inc., and Warburg Pincus also participated in the equity round.
The company will use the proceeds from the financing to increase production capabilities and accelerate commercial expansion of its Tablo®Hemodialysis System in acute and chronic care markets in the United States. Designed to reduce the cost and complexity of dialysis, Tablo expands how, when, and where dialysis can be provided.
Read More: https://www.businesswire.com/news/home/20180828005589/en/Outset-Medical-Closes-132-Million-Financing-Accelerate
Via: Business Wire
Via: WVU Medicine
MORGANTOWN, W.Va. – Surgeons at the WVU Heart and Vascular Institute are now offering a new minimally invasive treatment for patients with carotid artery disease.
TCAR (Transcarotid Artery Revascularization): The Next Step in the Evolution of Carotid Revascularization
Via: Endovascular Today
Since its introduction in the 1950s, carotid endarterectomy (CEA) has been considered the gold standard treatment option for carotid revascularization. However, in patients with high-risk anatomic and/or physiologic characteristics, CEA is associated with higher rates of adverse outcomes.1 Transfemoral carotid angioplasty and stenting (TF-CAS) was introduced over 2 decades ago as a potential alternative. However, its effectiveness compared to CEA remains unclear, and full adoption of TF-CAS has been hindered by a higher rate of periprocedural stroke.2
Providing advanced medical care in a patient's home once required the help of trained professionals. No longer -- new sensor technology is enabling a massive migration from hospitals to home care environments.
A study presented Monday at the American Diabetes Association (ADA) Scientific Sessions found that one-third of those who initially screened positive for prediabetes or diabetes were able to bring their blood sugar down to normal levels after taking part in a workforce-based intervention.
When not researching systems to prevent strokes, you might find Silk Road Medical CEO Erica Rogers on the dance floor or acting in a staging of “The Sound of Music.”
Via: PR Newswire
Digital Therapeutics Pioneer Launches Comprehensive, Personalized Solution for Obesity-Related Chronic Disease
Compared with carotid endarterectomy, transcarotid artery revascularization was associated with similar in-hospital outcomes in patients with carotid stenosis, according to data presented at the Society for Vascular Surgery Vascular Annual Meeting.
Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension.
Silk Road Medical Announces Key Events for Society for Vascular Surgery 2018 Vascular Annual Meeting
Via: Business Wire
SUNNYVALE, Calif.--(BUSINESS WIRE)--Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, today announced key events at the upcoming Society for Vascular Surgery 2018 Vascular Annual Meeting (VAM) June 20-23 at the Hynes Convention Center in Boston. These include real-world data presentations comparing the company’s TransCarotid Artery Revascularization (TCAR) procedure to transfemoral carotid artery stenting (TFCAS) and carotid endarterectomy (CEA), as well as other company-sponsored events about TCAR.